Literature DB >> 30413671

Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.

Awadalkareem Adam1, Marcia Woda1, Sonia Kounlavouth1, Alan L Rothman1, Richard G Jarman2, Josephine H Cox3, Julie E Ledgerwood3, Gregory D Gromowski2, Jeffrey R Currier2, Heather Friberg2, Anuja Mathew4.   

Abstract

Dengue virus (DENV) and Zika virus (ZIKV) are mosquito-borne pathogens that have a significant impact on human health. Immune sera, mAbs, and memory B cells (MBCs) isolated from patients infected with one DENV type can be cross-reactive with the other three DENV serotypes and even more distantly related flaviviruses such as ZIKV. Conventional ELISPOTs effectively measure Ab-secreting B cells but because they are limited to the assessment of a single Ag at a time, it is challenging to distinguish serotype-specific and cross-reactive MBCs in the same well. We developed a novel multifunction FluoroSpot assay using fluorescently labeled DENV and ZIKV (FLVs) that measures the cross-reactivity of Abs secreted by single B cells. Conjugation efficiency and recognition of FLVs by virus-specific Abs were confirmed by flow cytometry. Using a panel of DENV immune, ZIKV immune, and naive PBMC, FLVs were able to simultaneously detect DENV serotype-specific, ZIKV-specific, DENV serotype cross-reactive, and DENV/ZIKV cross-reactive Abs secreted by individual MBCs. Our findings indicate that the FLVs are sensitive and specific tools to detect specific and cross-reactive MBCs. These reagents will allow the assessment of the breadth as well as the durability of DENV/ZIKV B cell responses following vaccination or natural infection. This novel approach using FLVs in a FluoroSpot assay can be applied to other diseases such as influenza in which prior immunity with homosubtype- or heterosubtype-specific MBCs may influence subsequent infections.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30413671      PMCID: PMC6289764          DOI: 10.4049/jimmunol.1800892

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  B-cell responses during primary and secondary dengue virus infections in humans.

Authors:  Anuja Mathew; Kim West; Siripen Kalayanarooj; Robert V Gibbons; Anon Srikiatkhachorn; Sharone Green; Daniel Libraty; Smita Jaiswal; Alan L Rothman
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

Authors:  Shane Crotty; Rachael D Aubert; John Glidewell; Rafi Ahmed
Journal:  J Immunol Methods       Date:  2004-03       Impact factor: 2.303

Review 3.  Challenges of Vaccine Development for Zika Virus.

Authors:  Marcia A Blackman; In-Jeong Kim; Jr-Shiuan Lin; Stephen J Thomas
Journal:  Viral Immunol       Date:  2017-12-11       Impact factor: 2.257

4.  Development of antibody biomarkers of long term and recent dengue virus infections.

Authors:  Eduardo J M Nascimento; James W Huleatt; Marli T Cordeiro; Priscila M S Castanha; James K George; Eduard Grebe; Alex Welte; Monique Brown; Donald S Burke; Ernesto T A Marques
Journal:  J Virol Methods       Date:  2018-04-21       Impact factor: 2.014

5.  Dengue viruses cluster antigenically but not as discrete serotypes.

Authors:  Leah C Katzelnick; Judith M Fonville; Gregory D Gromowski; Jose Bustos Arriaga; Angela Green; Sarah L James; Louis Lau; Magelda Montoya; Chunling Wang; Laura A VanBlargan; Colin A Russell; Hlaing Myat Thu; Theodore C Pierson; Philippe Buchy; John G Aaskov; Jorge L Muñoz-Jordán; Nikos Vasilakis; Robert V Gibbons; Robert B Tesh; Albert D M E Osterhaus; Ron A M Fouchier; Anna Durbin; Cameron P Simmons; Edward C Holmes; Eva Harris; Stephen S Whitehead; Derek J Smith
Journal:  Science       Date:  2015-09-18       Impact factor: 47.728

6.  Single-Cell Analysis of B Cell/Antibody Cross-Reactivity Using a Novel Multicolor FluoroSpot Assay.

Authors:  Alexandros Hadjilaou; Angela M Green; Josefina Coloma; Eva Harris
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

7.  Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones.

Authors:  S J Gagnon; W Zeng; I Kurane; F A Ennis
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

Review 8.  The human antibody response to dengue virus infection.

Authors:  Wahala M P B Wahala; Aravinda M de Silva
Journal:  Viruses       Date:  2011-11-25       Impact factor: 5.048

Review 9.  The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.

Authors:  Félix A Rey; Karin Stiasny; Marie-Christine Vaney; Mariano Dellarole; Franz X Heinz
Journal:  EMBO Rep       Date:  2017-12-27       Impact factor: 8.807

10.  Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus.

Authors:  Petraleigh Pantoja; Erick X Pérez-Guzmán; Idia V Rodríguez; Laura J White; Olga González; Crisanta Serrano; Luis Giavedoni; Vida Hodara; Lorna Cruz; Teresa Arana; Melween I Martínez; Mariah A Hassert; James D Brien; Amelia K Pinto; Aravinda de Silva; Carlos A Sariol
Journal:  Nat Commun       Date:  2017-06-23       Impact factor: 14.919

View more
  9 in total

1.  A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine.

Authors:  Awadalkareem Adam; Qing Shi; Binbin Wang; Jing Zou; Junhua Mai; Samantha R Osman; Wenzhe Wu; Xuping Xie; Patricia V Aguilar; Xiaoyong Bao; Pei-Yong Shi; Haifa Shen; Tian Wang
Journal:  Transl Res       Date:  2022-06-08       Impact factor: 10.171

Review 2.  Measuring single-cell protein secretion in immunology: Technologies, advances, and applications.

Authors:  Olivia T M Bucheli; Ingibjörg Sigvaldadóttir; Klaus Eyer
Journal:  Eur J Immunol       Date:  2021-04-01       Impact factor: 5.532

Review 3.  Approaches to Interrogating the Human Memory B-Cell and Memory-Derived Antibody Repertoire Following Dengue Virus Infection.

Authors:  Zoe L Lyski; William B Messer
Journal:  Front Immunol       Date:  2019-06-06       Impact factor: 7.561

4.  A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission.

Authors:  Awadalkareem Adam; Camila R Fontes-Garfias; Vanessa V Sarathy; Yang Liu; Huanle Luo; Emily Davis; Wenqian Li; Antonio E Muruato; Binbin Wang; Renat Ahatov; Yoseph Mahmoud; Chao Shan; Samantha R Osman; Steven G Widen; Alan D T Barrett; Pei-Yong Shi; Tian Wang
Journal:  NPJ Vaccines       Date:  2021-02-17       Impact factor: 7.344

5.  Optimized production and immunogenicity of an insect virus-based chikungunya virus candidate vaccine in cell culture and animal models.

Authors:  Awadalkareem Adam; Huanle Luo; Samantha R Osman; Binbin Wang; Christopher M Roundy; Albert J Auguste; Kenneth S Plante; Bi-Hung Peng; Saravanan Thangamani; Elena I Frolova; Ilya Frolov; Scott C Weaver; Tian Wang
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

6.  Analysis of allelic cross-reactivity of monoclonal IgG antibodies by a multiplexed reverse FluoroSpot assay.

Authors:  Henriette Hoffmann-Veltung; Nsoh Godwin Anabire; Michael Fokuo Ofori; Peter Janhmatz; Niklas Ahlborg; Lars Hviid; Maria Del Pilar Quintana
Journal:  Elife       Date:  2022-07-15       Impact factor: 8.713

7.  Cross-reactive inhibitory antibody and memory B cell responses to variant strains of Duffy binding protein II at post-Plasmodium vivax infection.

Authors:  Pongsakorn Thawornpan; Siriruk Changrob; Piyawan Kochayoo; Kittikorn Wangriatisak; Francis B Ntumngia; Sai Lata De; Eun-Taek Han; John H Adams; Patchanee Chootong
Journal:  PLoS One       Date:  2022-10-18       Impact factor: 3.752

8.  IL-21 in Conjunction with Anti-CD40 and IL-4 Constitutes a Potent Polyclonal B Cell Stimulator for Monitoring Antigen-Specific Memory B Cells.

Authors:  Fridolin Franke; Greg A Kirchenbaum; Stefanie Kuerten; Paul V Lehmann
Journal:  Cells       Date:  2020-02-13       Impact factor: 6.600

9.  A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus.

Authors:  Hyeree Choi; Sagar B Kudchodkar; Michelle Ho; Emma L Reuschel; Erin Reynolds; Ziyang Xu; Devivasha Bordoloi; Kenneth E Ugen; Pablo Tebas; Joseph Kim; Mohamed Abdel-Mohsen; Saravanan Thangamani; David B Weiner; Kar Muthumani
Journal:  PLoS Negl Trop Dis       Date:  2020-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.